Why the study?
Oral antiplatelet and anticoagulant drugs are widely used among dental patients, but controversy persists regarding their clinical management, particularly focusing on oral surgery.
Does maintaining antithrombotic therapy increase the risk of uncontrollable bleeding in patients undergoing oral surgery?
Does maintaining antithrombotic therapy increase the risk of uncontrollable bleeding in patients undergoing oral surgery?
Routine oral surgery can be safely performed in patients on antiplatelet or anticoagulant therapy without discontinuing their medication, using local hemostatic measures to control bleeding.
Supports individualized continuation of therapy with local hemostasis in oral surgery; leaves open need for prospective trials to refine risk stratification.
No takes yet. Share an insight, caveat, or question.
Costa-Tort et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: